Payment to Healthy Volunteers in Clinical Research: The Research Subject's Perspective

被引:22
作者
Czarny, M. J. [2 ]
Kass, N. E. [3 ,4 ]
Flexner, C. [1 ]
Carson, K. A. [5 ]
Myers, R. K. [6 ]
Fuchs, E. J. [1 ]
机构
[1] Johns Hopkins Univ, Dept Med, Div Clin Pharmacol, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA
[4] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[6] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, Dept Gen Pediat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
INFORMED-CONSENT; PARTICIPATION;
D O I
10.1038/clpt.2009.222
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although there is much discussion regarding the ethics of making payments to healthy volunteers for participating in clinical research, little data are available from the point of view of the volunteers as to what they would consider to be fair payment. The objectives of this study were to determine healthy volunteers' estimates of appropriate payments for participation in hypothetical clinical trials in order to explore the reasoning behind these estimates and to examine the association between volunteer demographics and payment expectations. Sixty participants with previous experience as healthy volunteers in research studies were presented with four hypothetical studies and interviewed about their impressions of burden and risks involved in the studies. They were also asked to estimate an appropriate payment to the volunteers for each of the studies. For each of the studies, the payment estimates made by the participants varied over a wide range. However, each individual tended to be consistent in estimate placement within this range. No demographic factor was significantly associated with the estimated study payment. Subjects frequently mentioned risk and logistical burden as factors that should determine payment levels. Healthy volunteer subjects appear to have individualized yet consistent methods of arriving at estimates of payments for participating in clinical studies. These estimates are based on each subject's perception of study burden and associated risk.
引用
收藏
页码:286 / 293
页数:8
相关论文
共 21 条
[1]  
Ackerman Terrence F, 1989, IRB, V11, P1, DOI 10.2307/3564170
[2]   WEIGHT OF FINANCIAL REWARD IN THE DECISION BY MEDICAL-STUDENTS AND EXPERIENCED HEALTHY-VOLUNTEERS TO PARTICIPATE IN CLINICAL-TRIALS [J].
BIGORRA, J ;
BANOS, JE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (05) :443-446
[3]  
CUNNY KA, 1994, CLIN THER, V16, P273
[4]  
CUNNY KA, 1994, CLIN THER, V16, P271
[5]  
DESAINTONGE DMC, 1988, PHARM MED, V3, P45
[6]   What's the price of a research subject? Approaches to payment for research participation [J].
Dickert, N ;
Grady, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) :198-203
[7]   Improving informed consent and enhancing recruitment for research by understanding economic behavior [J].
Dunn, LB ;
Gordon, NE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05) :609-612
[8]  
*J HOPK MED I REV, ORG POL PAYM REM HUM
[9]   Balancing justice and autonomy in clinical research with healthy volunteers [J].
Kass, N. E. ;
Myers, R. ;
Fuchs, E. J. ;
Carson, K. A. ;
Flexner, C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 82 (02) :219-227
[10]  
Latterman Jessica, 2001, American Journal of Bioethics, V1, P45, DOI 10.1162/152651601300169040